Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-κB signaling pathways

Feb 23, 2017Oncotarget

Thymol reduces inflammation in the uterus caused by bacterial toxins by controlling immune and stress-related signaling pathways

AI simplified

Abstract

Thymol markedly alleviated LPS-induced pathological injury and inflammation in mouse endometritis.

  • Thymol reduced myeloperoxidase activity and the production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in vivo.
  • In vitro studies showed that thymol inhibited the expression of TNF-α, IL-1β, inducible nitric oxide synthase, and cyclooxygenase-2 in a dose-dependent manner.
  • Thymol treatment inhibited the expression of the Toll-like receptor 4-mediated nuclear factor-κB pathway.
  • Silencing of TLR4 blocked the activation of the NF-κB pathway.
  • Thymol also reduced LPS-induced reactive oxygen species production in a dose-dependent manner.

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free